Skip to main content
Erschienen in: International Journal of Diabetes in Developing Countries 3/2020

19.02.2020 | Original article

Beliefs of Caribbean type 2 diabetes patients towards insulin therapy and prescription

verfasst von: Chidum E. Ezenwaka, Philip Onuoha, Rian Extavour, Safiya Yearwood

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Background and aim

Previous research studies have shown that poorly controlled type 2 diabetes patients do not receive insulin therapy because of the resistance of the patients to insulin therapy. This study aimed to assess the belief of Caribbean insulin-naïve type 2 diabetes patients on insulin therapy.

Methods

Five hundred ten insulin-naïve type 2 diabetes patients who have had diabetes for at least 5 years were recruited for a questionnaire interview. The questionnaire was a modified version of a previously validated research questionnaire. Data collected was analysed with SPSS software using chi-square to test for significances.

Results

The majority of the patients have had diabetes for > 10 years and take > 2 different diabetes medications daily. About 67% and 81% of the patients do not believe that insulin therapy will cause them hypoglycemia and weight gain respectively. Similarly, a significant percentage does not believe that taking insulin will interfere with their normal lifestyle activities (72.2%, p = 0.048). Although a majority (64%) of the patients believe that taking insulin translates to personal failure in optimal blood glucose control, 90% do not believe that taking insulin will cause people to treat them differently. A majority of the patients do not believe that taking insulin will be helpful in preventing long-term diabetes complications (63.9%, p = 0.001), though 51% thought it would make them feel better.

Conclusion

Contrary to several reports, this study shows that insulin-naïve Caribbean type 2 diabetes patients do not have a significant negative perception towards insulin therapy. This finding might be related to the socio-cultural background of the patients studied.
Literatur
1.
Zurück zum Zitat Ezenwaka C, Onuoha P, Olukoga A. Challenges of self-monitoring of blood glucose in Caribbean type-2 diabetes patients. Int J Diabetes Dev Ctries. 2013;33(3):178–80.CrossRef Ezenwaka C, Onuoha P, Olukoga A. Challenges of self-monitoring of blood glucose in Caribbean type-2 diabetes patients. Int J Diabetes Dev Ctries. 2013;33(3):178–80.CrossRef
2.
Zurück zum Zitat Ezenwaka CE, Nwagbara E, Seales D, Okali F, Hussaini S, Raja B, et al. A comparative study of the prevalence of components of the metabolic syndrome in type 2 diabetic patients in two Caribbean Islands using the New International Diabetes Federation definition. Arch Physiol Biochem. 2007;113(4–5):202–10.CrossRef Ezenwaka CE, Nwagbara E, Seales D, Okali F, Hussaini S, Raja B, et al. A comparative study of the prevalence of components of the metabolic syndrome in type 2 diabetic patients in two Caribbean Islands using the New International Diabetes Federation definition. Arch Physiol Biochem. 2007;113(4–5):202–10.CrossRef
3.
Zurück zum Zitat Ezenwaka CE, Kalloo R. Postprandial glucose control in type 2 diabetic patients visiting two different primary care clinics in Trinidad, West Indies. West Indian Med J. 2004;53(6):392–9.PubMed Ezenwaka CE, Kalloo R. Postprandial glucose control in type 2 diabetic patients visiting two different primary care clinics in Trinidad, West Indies. West Indian Med J. 2004;53(6):392–9.PubMed
4.
Zurück zum Zitat Ezenwaka CE, Okoye O, Esonwune C, Onuoha P, Dioka C, Osuji C, et al. High prevalence of abdominal obesity increases the risk of the metabolic syndrome in Nigerian type 2 diabetes patients: using the IDF world-wide definition. Metab Syndr Relat Disord. 2014;12(5):277–82.CrossRef Ezenwaka CE, Okoye O, Esonwune C, Onuoha P, Dioka C, Osuji C, et al. High prevalence of abdominal obesity increases the risk of the metabolic syndrome in Nigerian type 2 diabetes patients: using the IDF world-wide definition. Metab Syndr Relat Disord. 2014;12(5):277–82.CrossRef
5.
Zurück zum Zitat Ezenwaka CE, Okoye O, Esonwune C, Dioka C, Onuoha P, Osuji C, et al. Is diabetes patients’ knowledge of laboratory tests for monitoring blood glucose levels associated with better glycemic control? Arch Physiol Biochem. 2014;120(2):86–90.CrossRef Ezenwaka CE, Okoye O, Esonwune C, Dioka C, Onuoha P, Osuji C, et al. Is diabetes patients’ knowledge of laboratory tests for monitoring blood glucose levels associated with better glycemic control? Arch Physiol Biochem. 2014;120(2):86–90.CrossRef
6.
Zurück zum Zitat UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef
7.
Zurück zum Zitat Home PD, Boulton AJM, Jimenez J, Landgraf R, Osterbrink B, Christiansen JS. Issues relating to the early or earlier use of insulin in type 2 diabetes. Practical Diabetes Int. 2003;20:63–71.CrossRef Home PD, Boulton AJM, Jimenez J, Landgraf R, Osterbrink B, Christiansen JS. Issues relating to the early or earlier use of insulin in type 2 diabetes. Practical Diabetes Int. 2003;20:63–71.CrossRef
8.
Zurück zum Zitat Brown JB, Nichols GA, Perry A. The burden of treatment failure in type 2 diabetes. Diabetes Care. 2004;27:1535–40.CrossRef Brown JB, Nichols GA, Perry A. The burden of treatment failure in type 2 diabetes. Diabetes Care. 2004;27:1535–40.CrossRef
9.
Zurück zum Zitat Dailey GE. Early insulin: an important therapeutic strategy. Diabetes Care. 2005;28:220–1.CrossRef Dailey GE. Early insulin: an important therapeutic strategy. Diabetes Care. 2005;28:220–1.CrossRef
10.
Zurück zum Zitat Davidson MB. Early insulin therapy for type 2 diabetes. Diabetes Care. 2005;28:222–4.CrossRef Davidson MB. Early insulin therapy for type 2 diabetes. Diabetes Care. 2005;28:222–4.CrossRef
11.
Zurück zum Zitat Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, et al. Resistance to insulin therapy among patients and providers: results of the cross-national diabetes attitudes, wishes and needs (DAWN) study. Diabetes Care. 2005;28:2673–9.CrossRef Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, et al. Resistance to insulin therapy among patients and providers: results of the cross-national diabetes attitudes, wishes and needs (DAWN) study. Diabetes Care. 2005;28:2673–9.CrossRef
12.
Zurück zum Zitat Leslie CA, Satin-Rapaport W, Matheson D, Stone R, Enfield G. Psychological insulin resistance: a missed diagnosis? Diabetes Spectrum. 1994;7:52–7. Leslie CA, Satin-Rapaport W, Matheson D, Stone R, Enfield G. Psychological insulin resistance: a missed diagnosis? Diabetes Spectrum. 1994;7:52–7.
13.
Zurück zum Zitat Leslie CA, Satin-Rapaport W. Psychological insulin resistance: a challenge for diabetes patients and health care professionals. J of New Developments Clin Med. 1995;13:21–7. Leslie CA, Satin-Rapaport W. Psychological insulin resistance: a challenge for diabetes patients and health care professionals. J of New Developments Clin Med. 1995;13:21–7.
14.
Zurück zum Zitat Rubin R, Peyrot M. Psychological issues and treatments in people with diabetes. J Clin Psychol. 2001;57:457–78.CrossRef Rubin R, Peyrot M. Psychological issues and treatments in people with diabetes. J Clin Psychol. 2001;57:457–78.CrossRef
15.
Zurück zum Zitat Korytkowski M. When oral agents fail: practical barriers to starting insulin. Int J Obes. 2002;26(Suppl. 3):S18–24.CrossRef Korytkowski M. When oral agents fail: practical barriers to starting insulin. Int J Obes. 2002;26(Suppl. 3):S18–24.CrossRef
16.
Zurück zum Zitat Koerbel G, Korytkowski M. Insulin-therapy resistance: another form of insulin resistance in type 2 diabetes. Practical Diabetology. 2003;22:36–40. Koerbel G, Korytkowski M. Insulin-therapy resistance: another form of insulin resistance in type 2 diabetes. Practical Diabetology. 2003;22:36–40.
17.
Zurück zum Zitat Peyrot M. Psychological insulin resistance: overcoming barriers to insulin therapy. Practical Diabetology. 2004;23:6–12. Peyrot M. Psychological insulin resistance: overcoming barriers to insulin therapy. Practical Diabetology. 2004;23:6–12.
18.
Zurück zum Zitat Funnell MM, Kruger DF, Spencer M. Self-management support for insulin therapy in type 2 diabetes. Diabetes Educ. 2004;30:274–80.CrossRef Funnell MM, Kruger DF, Spencer M. Self-management support for insulin therapy in type 2 diabetes. Diabetes Educ. 2004;30:274–80.CrossRef
19.
Zurück zum Zitat Polonsky WH, Jackson RA. What’s so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes. Clinical Diabetes. 2004;22:147–50.CrossRef Polonsky WH, Jackson RA. What’s so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes. Clinical Diabetes. 2004;22:147–50.CrossRef
21.
Zurück zum Zitat Enwere OO, Salako BL, Falade CO. Prescription and cost consideration at a diabetic clinic in Ibadan, Nigeria: a report. Annals of Ibadan Postgraduate Medicine. 2006;4:32–6. Enwere OO, Salako BL, Falade CO. Prescription and cost consideration at a diabetic clinic in Ibadan, Nigeria: a report. Annals of Ibadan Postgraduate Medicine. 2006;4:32–6.
22.
Zurück zum Zitat Sobngwi E, Ndour-Mbaye M, Boateng KA, Ramaiya KL, Njenga EW, Diop SN, et al. Type 2 diabetes control and complications in specialized diabetes care centres of six sub-Saharan African countries: the Diabcare Africa study. Diabetes Res Clin Pract. 2012;95(1):30–6.CrossRef Sobngwi E, Ndour-Mbaye M, Boateng KA, Ramaiya KL, Njenga EW, Diop SN, et al. Type 2 diabetes control and complications in specialized diabetes care centres of six sub-Saharan African countries: the Diabcare Africa study. Diabetes Res Clin Pract. 2012;95(1):30–6.CrossRef
23.
Zurück zum Zitat Escalada J, DomingoOrozco-Beltran D, Morillas C, Alvarez-Guisasola F, Gomez-Peralta F, Mata-Cases M, et al. Attitudes towards insulin initiation in type 2 diabetes patients among healthcare providers: a survey research. Diabetes Res Clin Pract. 2016;122:46–53.CrossRef Escalada J, DomingoOrozco-Beltran D, Morillas C, Alvarez-Guisasola F, Gomez-Peralta F, Mata-Cases M, et al. Attitudes towards insulin initiation in type 2 diabetes patients among healthcare providers: a survey research. Diabetes Res Clin Pract. 2016;122:46–53.CrossRef
24.
Zurück zum Zitat Miller GJ, Maude GH, Beckles GLA. Incidence of hypertension and non-insulin dependent diabetes mellitus and associated risk factors in a rapidly developing Caribbean community: the St James survey, Trinidad. J Epidemiol Community Health. 1996;50:497–504.CrossRef Miller GJ, Maude GH, Beckles GLA. Incidence of hypertension and non-insulin dependent diabetes mellitus and associated risk factors in a rapidly developing Caribbean community: the St James survey, Trinidad. J Epidemiol Community Health. 1996;50:497–504.CrossRef
25.
Zurück zum Zitat Ezenwaka CE, Offiah NV. Differences in glycemic control and cardiovascular risk in primary care patients with type 2 diabetes in West Indies. Clin Exp Med. 2001;1(2):91–8.CrossRef Ezenwaka CE, Offiah NV. Differences in glycemic control and cardiovascular risk in primary care patients with type 2 diabetes in West Indies. Clin Exp Med. 2001;1(2):91–8.CrossRef
26.
Zurück zum Zitat Ezenwaka CE. Metabolic control of type 2 diabetic patients commonly treated with sulphonylureas in a developing country. East Afr Med J. 2003;80(4):175–80.PubMed Ezenwaka CE. Metabolic control of type 2 diabetic patients commonly treated with sulphonylureas in a developing country. East Afr Med J. 2003;80(4):175–80.PubMed
27.
Zurück zum Zitat Ezenwaka C, Nwagbara E, Seales D, Okali F, Hussaini S, Bn R, et al. Prediction of 10-year coronary heart disease risk in Caribbean type 2 diabetic patients using the UKPDS Risk Engine. Int J Cardiol. 2009;132:348–53.CrossRef Ezenwaka C, Nwagbara E, Seales D, Okali F, Hussaini S, Bn R, et al. Prediction of 10-year coronary heart disease risk in Caribbean type 2 diabetic patients using the UKPDS Risk Engine. Int J Cardiol. 2009;132:348–53.CrossRef
30.
Zurück zum Zitat Polonsky WH, Anderson BJ, Lohrer PA, Aponte JE, Jacobson AM, Cole CF. Insulin omission in women with IDDM. Diabetes Care. 1994;17:1178–85.CrossRef Polonsky WH, Anderson BJ, Lohrer PA, Aponte JE, Jacobson AM, Cole CF. Insulin omission in women with IDDM. Diabetes Care. 1994;17:1178–85.CrossRef
31.
Zurück zum Zitat Brod M, Alolga SL, Meneghini L. Barriers to initiating insulin in type 2 diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities. Patient. 2014;7:437–50.CrossRef Brod M, Alolga SL, Meneghini L. Barriers to initiating insulin in type 2 diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities. Patient. 2014;7:437–50.CrossRef
32.
Zurück zum Zitat Brod M, Kongsø JH, Lessard S, Christensen TL. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res. 2009;18(1):23–32.CrossRef Brod M, Kongsø JH, Lessard S, Christensen TL. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res. 2009;18(1):23–32.CrossRef
33.
Zurück zum Zitat United Kingdom Prospective Diabetes Study (UKPDS). Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):854–65.CrossRef United Kingdom Prospective Diabetes Study (UKPDS). Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):854–65.CrossRef
34.
Zurück zum Zitat Ezenwaka C, Eckel J. Prevention of diabetes complications in developing countries: time to intensify self-management education. Arch Physiol Biochem. 2011;117(5):251–3.CrossRef Ezenwaka C, Eckel J. Prevention of diabetes complications in developing countries: time to intensify self-management education. Arch Physiol Biochem. 2011;117(5):251–3.CrossRef
Metadaten
Titel
Beliefs of Caribbean type 2 diabetes patients towards insulin therapy and prescription
verfasst von
Chidum E. Ezenwaka
Philip Onuoha
Rian Extavour
Safiya Yearwood
Publikationsdatum
19.02.2020
Verlag
Springer India
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe 3/2020
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-020-00808-5

Weitere Artikel der Ausgabe 3/2020

International Journal of Diabetes in Developing Countries 3/2020 Zur Ausgabe